Annual Cash & Cash Equivalents
$60.08 M
-$67.60 M-52.94%
31 December 2023
Summary:
Rhythm Pharmaceuticals annual cash & cash equivalents is currently $60.08 million, with the most recent change of -$67.60 million (-52.94%) on 31 December 2023. During the last 3 years, it has fallen by -$40.77 million (-40.43%). RYTM annual cash & cash equivalents is now -52.94% below its all-time high of $127.68 million, reached on 31 December 2022.RYTM Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$47.52 M
-$114.15 M-70.61%
30 September 2024
Summary:
Rhythm Pharmaceuticals quarterly cash and cash equivalents is currently $47.52 million, with the most recent change of -$114.15 million (-70.61%) on 30 September 2024. Over the past year, it has dropped by -$17.07 million (-26.43%). RYTM quarterly cash and cash equivalents is now -77.42% below its all-time high of $210.48 million, reached on 30 June 2018.RYTM Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RYTM Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -52.9% | -26.4% |
| 3 y3 years | -40.4% | -48.5% |
| 5 y5 years | +21.3% | -33.7% |
RYTM Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -52.9% | +1.4% | -74.3% | at low |
| 5 y | 5 years | -52.9% | +21.3% | -74.3% | at low |
| alltime | all time | -52.9% | +818.7% | -77.4% | +626.6% |
Rhythm Pharmaceuticals Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $47.52 M(-70.6%) |
| June 2024 | - | $161.67 M(+202.6%) |
| Mar 2024 | - | $53.43 M(-11.1%) |
| Dec 2023 | $60.08 M(-52.9%) | $60.08 M(-7.0%) |
| Sept 2023 | - | $64.59 M(-44.2%) |
| June 2023 | - | $115.68 M(+5.5%) |
| Mar 2023 | - | $109.66 M(-14.1%) |
| Dec 2022 | $127.68 M(+115.5%) | $127.68 M(-31.0%) |
| Sept 2022 | - | $185.09 M(+63.5%) |
| June 2022 | - | $113.21 M(+44.1%) |
| Mar 2022 | - | $78.54 M(+32.6%) |
| Dec 2021 | $59.25 M(-41.3%) | $59.25 M(-35.9%) |
| Sept 2021 | - | $92.37 M(+33.2%) |
| June 2021 | - | $69.34 M(-20.5%) |
| Mar 2021 | - | $87.27 M(-13.5%) |
| Dec 2020 | $100.85 M | $100.85 M(+49.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2020 | - | $67.67 M(+14.5%) |
| June 2020 | - | $59.09 M(+5.9%) |
| Mar 2020 | - | $55.78 M(-10.5%) |
| Dec 2019 | $62.29 M(+25.7%) | $62.29 M(-13.1%) |
| Sept 2019 | - | $71.68 M(+13.6%) |
| June 2019 | - | $63.12 M(+50.2%) |
| Mar 2019 | - | $42.02 M(-15.2%) |
| Dec 2018 | $49.54 M(+44.7%) | $49.54 M(-14.9%) |
| Sept 2018 | - | $58.25 M(-72.3%) |
| June 2018 | - | $210.48 M(+387.6%) |
| Mar 2018 | - | $43.17 M(+26.1%) |
| Dec 2017 | $34.24 M(+423.5%) | $34.24 M(+22.6%) |
| Sept 2017 | - | $27.91 M(-4.4%) |
| June 2017 | - | $29.20 M(+346.5%) |
| Dec 2016 | $6.54 M(-81.2%) | $6.54 M |
| Dec 2015 | $34.87 M | - |
FAQ
- What is Rhythm Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Rhythm Pharmaceuticals?
- What is Rhythm Pharmaceuticals annual cash & cash equivalents year-on-year change?
- What is Rhythm Pharmaceuticals quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Rhythm Pharmaceuticals?
- What is Rhythm Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
What is Rhythm Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of RYTM is $60.08 M
What is the all time high annual cash & cash equivalents for Rhythm Pharmaceuticals?
Rhythm Pharmaceuticals all-time high annual cash & cash equivalents is $127.68 M
What is Rhythm Pharmaceuticals annual cash & cash equivalents year-on-year change?
Over the past year, RYTM annual cash & cash equivalents has changed by -$67.60 M (-52.94%)
What is Rhythm Pharmaceuticals quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of RYTM is $47.52 M
What is the all time high quarterly cash and cash equivalents for Rhythm Pharmaceuticals?
Rhythm Pharmaceuticals all-time high quarterly cash and cash equivalents is $210.48 M
What is Rhythm Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
Over the past year, RYTM quarterly cash and cash equivalents has changed by -$17.07 M (-26.43%)